TDE-HF-301 A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects with Pulmonary Hypertension (PH) in Heart Failure with Preserved Ejection Fraction (HFpEF)

Grants and Contracts Details

StatusFinished
Effective start/end date11/15/175/27/20

Funding

  • United Therapeutics Corporation: $29,371.00